Advanced Therapeutics (uk) Limited

Advanced Therapeutics Uk Ltd from Warwick UK: a small, active company founded 19 years ago, employs seven people, and holds £1,502,899 in assets. It’s a family business with three directors and two owners, boasting a 4.0 Google rating from three reviews. The company regularly imports optical and medical tools and devices, with 52 months of import activity recorded.

The company’s website highlights its specialization in insulin pump therapy, acting as the exclusive UK distributor for SOOIL Development Co., Ltd. Their flagship product, the Dana i System, is positioned as cutting-edge technology for managing glucose levels, particularly through its hybrid closed-loop system. They also offer a range of infusion sets designed for Dana Diabecare insulin pumps, catering to diverse user needs. The website is very detailed, and gives a lot of information about the pumps and the technology behind them.

Financially, Advanced Therapeutics Uk Ltd presents a mixed picture. Current assets have fallen by 27% to £1,100,000, and net assets have dropped significantly by 30% to £830,000. Bank borrowings have decreased by 4.4% to £73,000, but cash reserves have plummeted 70% to £23,000. Creditors have increased by 4.1% to £590,000. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows it to remain nimble, but the decline in equity is a cause for concern. The lack of a named auditor suggests the company is exempt from an audit as a small business.

The company’s focus on a niche market—insulin pump therapy—and its strong online presence suggest potential for growth, but the recent financial trends indicate a need for careful management.

Registered in England/Wales under the registration number 05517697, with a registered address at CV34 6YB, United Kingdom, Warwick, Warwickshire, Unit 6 T1300 Plato Close, Tachbrook Park.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.